Gilead Sciences, Inc.
GILD
$138.92
$0.560.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 12.11% | -12.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.11% | -12.18% | |||
| Cost of Revenue | 9.27% | -10.80% | |||
| Gross Profit | 12.86% | -12.53% | |||
| SG&A Expenses | 33.66% | -19.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.46% | -14.85% | |||
| Operating Income | -3.88% | -7.70% | |||
| Income Before Tax | -497.44% | 24.16% | |||
| Income Tax Expenses | -56.71% | 632.38% | |||
| Earnings from Continuing Operations | -619.35% | -7.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -619.35% | -7.42% | |||
| EBIT | -3.88% | -7.70% | |||
| EBITDA | -2.83% | -6.19% | |||
| EPS Basic | -618.93% | -7.42% | |||
| Normalized Basic EPS | -6.34% | -7.71% | |||
| EPS Diluted | -624.84% | -7.41% | |||
| Normalized Diluted EPS | -5.44% | -7.77% | |||
| Average Basic Shares Outstanding | 0.08% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.88% | 0.08% | |||
| Dividend Per Share | 0.00% | 3.80% | |||
| Payout Ratio | -1.19% | 0.13% | |||